Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Future acne treatments should aggressively target inflammation to prevent scarring.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

New compounds may soon be tested to treat excessive hair growth in women.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Menopause can cause skin issues, and seeing a dermatologist helps.

PCOS is a major cause of infertility and requires personalized treatment.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.